HOB Biotech Group Corp Ltd (688656) — Capital Reinvestment Ratio
HOB Biotech Group Corp Ltd (688656) has a Capital Reinvestment Ratio of 0.33x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥34.39 Million) in capital expenditures (CN¥11.30 Million). See debt-free asset ratio of HOB Biotech Group Corp Ltd to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
HOB Biotech Group Corp Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks HOB Biotech Group Corp Ltd's Capital Reinvestment Ratio across 9 annual periods. Check 688656 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for HOB Biotech Group Corp Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for HOB Biotech Group Corp Ltd from 2016 to 2024. For live market cap and broader valuation context, see HOB Biotech Group Corp Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.53x | CN¥101.22 Million | CN¥155.37 Million | ▼ -11.5% |
| 2023 | 1.73x | CN¥102.69 Million | CN¥178.03 Million | ▼ -54.1% |
| 2022 | 3.78x | CN¥58.31 Million | CN¥220.21 Million | ▲ +135.7% |
| 2021 | 1.60x | CN¥104.79 Million | CN¥167.89 Million | ▲ +63.6% |
| 2020 | 0.98x | CN¥58.22 Million | CN¥57.01 Million | ▲ +93.0% |
| 2019 | 0.51x | CN¥68.57 Million | CN¥34.80 Million | ▼ -11.5% |
| 2018 | 0.57x | CN¥46.51 Million | CN¥26.66 Million | ▼ -38.7% |
| 2017 | 0.94x | CN¥22.26 Million | CN¥20.82 Million | ▼ -65.0% |
| 2016 | 2.67x | CN¥6.42 Million | CN¥17.15 Million | — |